David Yang, MD
Urology · Mankato, MNNPI 1417337866
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $292,245 of the $298,368 with a category attached, or 97.9%. Johnson & Johnson accounts for 97.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $255,731 and has fallen 99.7% since, to $640 in 2025. Among urology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $5850.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$292K
- Coloplast$3K
- Boston Scientific$3K
- Endo USA, Inc.$330
- Calyxo, Inc.$138
- Olympus America Inc.$125
- plus $96 from 2 others
What the payments were for
- Consulting fees$292,24598%
- Travel & lodging$3,7011%
- Food & beverage$2,2421%
- Education$1800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $291,915 |
| Coloplast | 14 | $2,906 |
| Boston Scientific | 22 | $2,857 |
| Endo USA, Inc. | 1 | $330 |
| Calyxo, Inc. | 1 | $138 |
| Olympus America Inc. | 1 | $125 |
| AstraZeneca | 1 | $68 |
| Endo Pharmaceuticals Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$2,758
- AMS$1,549
- GENERAL ERECTILE DYSFUNCTION$365
- GENERAL - THERAPIES$164
- CVAC Aspiration System$138
- SpaceOAR VUE System - 10mL$133
- iTIND System$125
- REZUM$114
How this compares
$298,368 in reported general payments places this provider in the 95th percentile of 247 urology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 17 | $7,848 |
| Tamsulosin Hcl | 130 | $1,605 |
| Finasteride | 53 | $685 |
| Cefdinir | 66 | $645 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $284 |
| Oxybutynin Chloride | 19 | $141 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $82 |
| Amoxicillin | 19 | $71 |
| Oxycodone Hcl | 28 | $58 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $58 |
Paid to pharmacies, not to this prescriber.
Other urology in Mankato
- Christina GodwinMankato$6K
- Steven BernsteinEdina$271K
- Ayman SoubraMinneapolis$204K
- Sean ElliottMinneapolis$163K
- Jonathan WarnerRochester$144K
- Steven SiegelWoodbury$140K
- Aaron MilbankWoodbury$97K
- Tobias KohlerRochester$89K
- Joseph MahonEdina$86K
- Nissrine NakibMinneapolis$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.